Novo Nordisk record profits with weight-loss-drug demand boost
2023-11-02
3
Fiona Cincotta, Analyst from City Index talks with CGTN Europe on Novo Nordisk Q3 result.
Please enable JavaScript to view the
comments powered by Disqus.
Videos similaires
Novo Nordisk reports Q1 profits o $3.65 BN as demand for weightloss drug soars
Novo Nordisk cuts supply of obesity drug Wegovy in the US due to surging demand
Ten Pharma Firms Form Non-profit to Speed Up New Drug Trials; InBalance Health Launches New Nutrition Bars; Novo Nordisk Ranks High on Carbon Disclosure Project - Health Minute for September 27, 2012
Novo Nordisk earnings: sales of weight-loss drug Wegovy lower than expected
'Stop Ripping Us Off.' Senate Grills Novo Nordisk on High Prices of Weight Loss Drugs Wegovy and Ozempic in US.
Novo Nordisk Shares Pop as New Obesity Drug Candidate Shows Impressive 13.1% Weight Loss in Early Trials
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
Novo Nordisk Boosts 2023 Outlook
Streetsmart Marketing Testimonial - From Loss Profits to increase Profits
Novo Nordisk Raises Sales Growth Outlook Despite Profit Miss. CEO Predicts 'Attractive Growth' Amidst Competition and Regulation Shifts.
